About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1170 record(s)
Req # A-2022-001097
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-11-10 for the medicinal ingredient sulfamethoxazole trimethoprim. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for sulfamethoxazole trimethoprim which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-11-10.Organization: Health Canada
February 2023
Req # A-2022-001116
Any documents or other communications to or from Health Canada, relating to the removal of Canadian Patent No. 2,712,614 from the Patent Register in respect of Drug Identification Numbers 02425483 and 02425491 on July 25, 2022.Organization: Health Canada
February 2023
Req # A-2022-001230
All document(s) submitted by Health Canada to the Patented Medicines Prices Review Board (PMPRB) as part of the consultation on the PMPRB's 2022 draft guidelines. The relevant period is from October 1 to December 7th.Organization: Health Canada
February 2023
Req # A-2022-001287
Dataset that tracks of loss-theft of opioid drug products reported to Health Canada - date range, August 18, 2020 to January 5, 2023.Organization: Health Canada
February 2023
Req # A-2022-001299
All communications with Google regarding any discussions/requests to censor/suspend/ban/promote/throttle/shadow ban an account or particular post, since January 1, 2020.Organization: Health Canada
February 2023
Req # A-2022-001306
All final documents pertaining to the Public Health Agency of Canada's (PHAC) social media plan for PHAC’s 2022 COVID-19 vaccine booster program. Timeframe: October 2019 to January 2023.Organization: Health Canada
February 2023
Req # A-2022-001328
All published peer-reviewed scientific studies by independent researchers based on specific human measurements of biochemical changes, and not computer models for heating that PROVE long-term exposure to 5G is safe for children, pregnant women, and electro hypersensitive individuals. All research into possible health effects of human exposure to radiofrequency electromagnetic radiation from wireless devices that Health Canada has carried out based on specific human measurements of biochemical changes, and not computer models for heating that PROVES long-term exposure to 5G is safe for children, pregnant women, and electro hypersensitive individuals.Organization: Health Canada
February 2023
Req # A-2022-001366
Since July 16, 2021, all acknowledgment letters issued by Health Canada confirming receipt of Abbreviated New Drug Submissions for Vilazodone Hydrochloride Tablets (10mg, 20mg, and 40mg).Organization: Health Canada
February 2023
Req # A-2022-001375
A copy of contract number EN578-211918/002/LS and any revisions, amendments or modifications thereto awarded to Record Express. For the time period 2020/01/01 to 2021/01/14, all records in the possession of Health Canada with respect to the Contract.Organization: Health Canada
February 2023
Req # A-2022-001383
A copy of contract number EN578-211918/002/LS and any revisions, amendments or modifications thereto awarded to RecordExpress. For the time period 2021/04/02 to 2023/02/02, all records in the possession of Health Canada with respect to the Contract.Organization: Health Canada
February 2023